DANIEL HAMSTRA to Brain Neoplasms
This is a "connection" page, showing publications DANIEL HAMSTRA has written about Brain Neoplasms.
Connection Strength
1.061
-
Outcomes of multidisciplinary management in pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e481-8.
Score: 0.185
-
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol. 2008 Jul 10; 26(20):3387-94.
Score: 0.152
-
Primary radiotherapy for childhood ependymoma? Lancet Oncol. 2007 Sep; 8(9):758-9; author reply 760-1.
Score: 0.144
-
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A. 2005 Nov 15; 102(46):16759-64.
Score: 0.127
-
Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study. J Neurooncol. 2005 Jul; 73(3):225-38.
Score: 0.124
-
From the guest editor: Proton therapy: current evidence, challenges, and future plans. Cancer J. 2014 Nov-Dec; 20(6):369-70.
Score: 0.059
-
Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol. 2013 Aug 21; 8:204.
Score: 0.055
-
Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res. 2011 Jul 15; 17(14):4751-60.
Score: 0.046
-
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol. 2010 May 01; 28(13):2293-9.
Score: 0.043
-
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med. 2009 May; 15(5):572-6.
Score: 0.040
-
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D. Clin Cancer Res. 2006 Mar 01; 12(5):1525-32.
Score: 0.033
-
Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res. 2004 Dec 01; 10(23):7852-9.
Score: 0.030
-
Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther. 2000 Jun; 7(12):1005-10.
Score: 0.022